It has been suggested that TMEM176A and TMEM176B inhibit the maturation and activation of dendritic cells in chronic spinal cord injury [53] and that TMEM176B impairs IL-1β secretion and reduces CD8+ T cell-dependent antitumor immunity [54]. This evidence concerns the gene IL1B and spinal cord injury.